DXR Shariah Compliance

Screening Methodology: AAOIFI

DOUBTFUL

Last Updated: April 19, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Daxor Corp (DXR)

Based on 6 analysts giving stock ratings to Daxor Corp in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
17
Buy
66
Hold
17
Sell
0
Strong Sell
0
Daxor Corp

Daxor Corp. Stock Analysis DXR

United States Health Care Micro Cap Report:
Daxor Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a diversified, closed-end management investment company. Its focus and operations are as a medical device manufacturing, company. The company specializes in blood volume measurement technology focused on blood volume testing innovation. The company markets the Blood Volume Analyzer (BVA)-100, the diagnostic blood test cleared by the FDA to provide objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000 tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a range of surgical and medical conditions, including reducing mortality and readmissions in heart failure and critical care. Its facility provides on-demand, next day blood volume analysis results. The company has several ongoing trials in the areas of heart failure treatment with support from the NIH and is under contract developing analyzers to improve combat casualty care with the United States Department of Defense.
Read More

Daxor Corp (DXR) Chart

Key Statistics of Daxor Corp (DXR)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$10.75$11.00

Today's Open

$10.75

Volume

2710.00

P/E Ratio (TTM)

6.91

52 Week Range

$7.20$14.76

Market Cap

54.66M

Avg. Volume

10.04K

Dividend Yield

-

Financial Metrics & Statements of Daxor Corp (DXR)

FAQ's for Daxor Corp (DXR)

  • According to Musaffa’s Shariah screening methodology, Daxor Corp (DXR) is currently classified as DOUBTFUL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.